Caprihans India Limited (BOM:509486)

India flag India · Delayed Price · Currency is INR
73.89
+0.23 (0.31%)
At close: Apr 29, 2026
-43.92%
Market Cap 1.18B
Revenue (ttm) 7.07B
Net Income (ttm) -516.70M
Shares Out 15.91M
EPS (ttm) -35.49
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,653
Average Volume 5,929
Open 72.00
Previous Close 73.66
Day's Range 72.00 - 77.50
52-Week Range 50.30 - 167.70
Beta 0.47
RSI 52.49
Earnings Date May 30, 2026

About Caprihans India

Caprihans India Limited engages in the pharmaceutical packaging business in India and internationally. The company also manufactures and sells rigid and flexible polyvinyl chloride (PVC) films, polyvinylidene chloride (PVDC) coated films, plastic extruded products, alu alu foils, and other allied products. In addition, it provides thermoforming blister films under the Duplex, Triplex, Ultra, Ultra Tx, Armour, Aclar, Excel, Exxtra, Optra, BAPP, Zymax, Zymax Tx, and Zymax PDP names; coldforming blister foils under the Venus, Venus PR, Venus SBC, ... [Read more]

Industry Miscellaneous Plastics Products
Founded 1946
Employees 540
Stock Exchange Bombay Stock Exchange
Ticker Symbol 509486
Full Company Profile

Financial Performance

In fiscal year 2025, Caprihans India's revenue was 7.40 billion, an increase of 6.36% compared to the previous year's 6.95 billion. Losses were -621.80 million, 20.5% more than in 2024.

Financial Statements

News

There is no news available yet.